A detailed history of Nuveen Asset Management, LLC transactions in Larimar Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 174,788 shares of LRMR stock, worth $1.08 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
174,788
Previous 210,828 17.09%
Holding current value
$1.08 Million
Previous $1.53 Million 25.13%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.3 - $10.68 $227,052 - $384,907
-36,040 Reduced 17.09%
174,788 $1.14 Million
Q2 2024

Aug 09, 2024

BUY
$6.33 - $9.89 $662,105 - $1.03 Million
104,598 Added 98.46%
210,828 $1.53 Million
Q1 2024

May 13, 2024

BUY
$4.2 - $13.28 $284,499 - $899,560
67,738 Added 175.98%
106,230 $806,000
Q4 2023

Feb 14, 2024

BUY
$2.35 - $4.71 $6,666 - $13,362
2,837 Added 7.96%
38,492 $175,000
Q2 2023

Aug 14, 2023

BUY
$3.13 - $5.27 $111,600 - $187,901
35,655 New
35,655 $111,000

Others Institutions Holding LRMR

About Larimar Therapeutics, Inc.


  • Ticker LRMR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,269,200
  • Market Cap $267M
  • Description
  • Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Its lead product candidate is CTI-1601, which is in Phase 1 clinical trial for the treatment of Friedreich's ataxia, a rare, progressive, and fatal genetic disease. T...
More about LRMR
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.